Henry Schein, Inc. (NASDAQ:HSIC) Holdings Cut by Creative Planning

Creative Planning reduced its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 7.8% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,582 shares of the company’s stock after selling 1,312 shares during the period. Creative Planning’s holdings in Henry Schein were worth $1,136,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in HSIC. Empirical Finance LLC grew its stake in Henry Schein by 3.5% during the 1st quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock worth $360,000 after buying an additional 160 shares during the last quarter. Covestor Ltd grew its position in shares of Henry Schein by 12.8% during the first quarter. Covestor Ltd now owns 1,511 shares of the company’s stock worth $114,000 after acquiring an additional 171 shares during the last quarter. Simplify Asset Management Inc. increased its holdings in shares of Henry Schein by 5.0% in the 2nd quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock worth $237,000 after acquiring an additional 175 shares during the period. Sequoia Financial Advisors LLC lifted its position in Henry Schein by 3.2% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company’s stock valued at $364,000 after purchasing an additional 176 shares during the last quarter. Finally, Studio Investment Management LLC boosted its stake in Henry Schein by 4.7% during the 2nd quarter. Studio Investment Management LLC now owns 4,502 shares of the company’s stock valued at $289,000 after purchasing an additional 204 shares during the period. 96.62% of the stock is owned by institutional investors.

Insider Transactions at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.14% of the stock is owned by insiders.

Henry Schein Stock Performance

NASDAQ:HSIC opened at $70.23 on Friday. The company has a 50-day moving average of $70.63 and a 200-day moving average of $69.78. The firm has a market cap of $8.99 billion, a price-to-earnings ratio of 23.83, a price-to-earnings-growth ratio of 2.00 and a beta of 0.86. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a twelve month low of $60.01 and a twelve month high of $82.63.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.01. The firm had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The firm’s revenue for the quarter was up .0% compared to the same quarter last year. During the same period last year, the firm posted $1.31 earnings per share. Analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Barrington Research restated an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research note on Friday, September 20th. JPMorgan Chase & Co. reduced their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. Evercore ISI increased their price target on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Finally, UBS Group decreased their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Henry Schein currently has a consensus rating of “Hold” and a consensus price target of $77.50.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.